Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting
JAMA Psychiatry May 11, 2022 Sina Nikayin, Taeho Greg Rhee, Maria Elena Cunningham et al. 43 citations
This comparative analysis examines the trajectory of depression severity among patients treated with intravenous ketamine or intranasal esketamine in a clinical setting.
DOI: 10.1001/jamapsychiatry.2022.1074 (opens in new tab)
Full text (opens in new tab)
Otorhinolaryngology
Neurology
Family medicine
Depression economics
+1